Back

Decision making for downgrading a cardiac resynchronization therapy device using cardiopulmonary exercise testing

17 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Cardiac Resynchronization Therapy Risk Factors and Risk Assessment EHRA Premium Access EHRA 2019

About the speaker

Photo
Doctor Madalena Coutinho Cruz

Hospital de Santa Marta, Lisbon (Portugal)

26 More presentations in this session

Presentation thumbnail
Statistical ranking of electromechanical dyssynchrony parameters for cardiac resynchronisation therapy
Doctor S. Cazeau (Paris, FR)
Abstract Slides
Presentation thumbnail
Left ventricular scar predicts remodeling in patients undergoing cardiac resynchronisation therapy - A retrospective analysis from a large tertiary centre
Ms K. Thomasson (Luton, GB)
Abstract Slides
Presentation thumbnail
Lead positioning for cardiac resynchronization therapy, a randomized trial comparing an active fixation bipolar left ventricular lead and a passive fixation quadripolar lead
Mr H. Keilegavlen (Bergen, NO)
Abstract Slides
Presentation thumbnail
Clinical outcome of cardiac resynchronization therapy in patients randomized to an active fixation bipolar left ventricular lead versus a passive quadripolar lead
Mr H. Keilegavlen (Bergen, NO)
Abstract Slides
Presentation thumbnail
Benefit of primary prophylactic ICD-therapy in nonischemic compared to ischemic cardiomyopathy with and without cardiac resynchronization therapy
Doctor T. Kleemann (Ludwigshafen, DE)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Cardiac Resynchronization Therapy

The Event

Event poster

EHRA 2019

17 March - 19 March 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources